Phase 2 Trial of a Novel COPD Treatment

from Out of the Blue: An AJRCCM Podcast · host American Thoracic Society

Drs. Stephen Rennard and Shawn Aaron discuss a manuscript from Dr. Rennard and his colleagues about using the CXCR2 antagonist MK-7123 to improve lung function in COPD. The podcast is moderated by AJRCCM podcast editor, Nitin Seam.

Episode metadata supplied by the publisher feed · Published May 1, 2015

Embed this episode

Attribution link and audio player

NOW PLAYING

Phase 2 Trial of a Novel COPD Treatment

0:00 27:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Out of the Blue: An AJRCCM Podcast?

This episode is 27 minutes long.

When was this Out of the Blue: An AJRCCM Podcast episode published?

This episode was published on May 1, 2015.

Can I download this Out of the Blue: An AJRCCM Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!